Millar, Douglas G.
Yang, S. Y. Cindy
Sayad, Azin
Zhao, Qingchuan
Nguyen, Linh T.
Warner, Kathrin
Sangster, Ami G.
Nakatsugawa, Munehide
Murata, Kenji
Wang, Ben X.
Shaw, Patricia
Clarke, Blaise
Bernardini, Marcus Q.
Pugh, Trevor
Thibault, Pierre
Hirano, Naoto
Perreault, Claude
Ohashi, Pamela S.
Funding for this research was provided by:
Terry Fox Research Institute
We Love You Connie Foundation
Article History
Received: 2 November 2022
Accepted: 16 February 2023
First Online: 21 March 2023
Declarations
:
: PSO holds options with Providence Therapeutics and Treadwell Therapeutics and is a member of the advisory board. N.H. has equity in Treadwell Therapeutics to which the technologies used in this study have been licensed.